United StatesBreaking News

Somnigroup International (NYSE:SGI) announced today that its proposed acquisition of Leggett & Platt (NYSE:LEG) has cleared a significant regulatory hurdle.

X-energy (NASDAQ:XE) reported total revenues and grant income of $43.4 million for the first quarter of 2026, marking a 109% increase compared to the same period in 2025.

Former Health Minister Wes Streeting vowed he would fight a battle against Mayor of Greater Manchester Andy Burnham if the two went head-to-head in a race for the leadership of the governing Labour Party. "He needs to set out his stall, I need to set out mine," Streeting said in conversation with Bloomberg's Francine Lacqua at the SXSW London tech festival Wednesday.

Sophie Huynh, senior cross asset strategist at BNP Paribas Asset Management, discusses the risk of a so-called bubble in the artificial intelligence trade space. "What I'm looking at much more is tokens rationing," she tells Bloomberg Television. "There's anecdotes here and there that we're consuming so much tokens at this point that there's not going to be enough," Huynh says. She also discusses the impact of the ongoing conflict in the Middle East on markets.

Alvotech (NASDAQ:ALVO) has officially resubmitted its Biologics License Applications (BLAs) to the U.S. Food and Drug Administration (FDA) for two of its lead biosimilar candidates: AVT05, a proposed biosimilar to Simponi and Simponi Aria (golimumab), and AVT06, a proposed biosimilar to Eylea (aflibercept) 2 mg.

111 (NASDAQ:YI) reported unaudited financial results for the first quarter of 2026 today, signaling the company's deepening transition toward a more lean and technology-oriented operating structure.

Biogen (NASDAQ:BIIB) and UCB have announced the release of positive results from the Phase 3 PHOENYCS GO clinical trial evaluating dapirolizumab pegol (DZP), an investigational treatment for systemic lupus erythematosus (SLE).

Pharming Group (NASDAQ:PHAR) announced today that the U.S. Food and Drug Administration (FDA) has accepted its resubmitted supplemental New Drug Application (sNDA) for Joenja (leniolisib).

Anna Edwards, Guy Johnson, Tom Mackenzie and Mark Cudmore break down today's key themes for analysts and investors on "Bloomberg: The Opening Trade."

Nigeria plans to refinance high-cost debt and raise funds to to help plug its budget deficit, leveraging strong investor confidence amid elevated oil prices fueled by the US-Iran conflict. Finance Minister Taiwo Oyedele spoke to Bloomberg's Jennifer Zabasajja in London.

SpaceX is seeking to raise $75 billion in an initial public offering that would be the biggest of all time. Elon Musk's rocket, satellite and artificial intelligence company plans to market about 555.6 million shares for $135 each, according to its filing Wednesday with the US Securities and Exchange Commission. Bloomberg's Manuel Baigorri reports.

Broadcom shares fell in extended trading after the company delivered a disappointing forecast for artificial intelligence chip revenue. Chief Executive Officer Hock Tan said the company $56 billion in AI chips in the fiscal year that ends in October. The forecast that fell short of the average estimate of $57.6 billion. Bloomberg's Neil Campling reports.